Today In Healthcare: Using AI To Fight Healthcare Fraud, Delta Variant Triggers More Vax Mandates And InComm Partners With Convey Health On OTC

COVID vaccine card

Today in healthcare, a study finds few companies use artificial intelligence (AI) in the fight against healthcare fraud, waste and abuse, and InComm Payments has partnered with Convey Health for over-the-counter healthcare services. Plus, the Delta variant leads to more vaccine mandates across the U.S and around the world.

Delta Variant Spread Leads To More Vax Mandates

The Delta variant of COVID-19 continues to wreak havoc on vaccinated Americans and people around the world who were just starting to get used to going wherever they wanted without a mask.

Representatives from almost 60 medical groups — such as the American Nurses Association and the American Medical Association — said Monday (July 26) they want to see mandatory vaccination policies for all healthcare workers, calling it an ethical obligation as the number of cases begins to surge again. The Veterans Administration, New York City, California and the NFL also adopted recent vaccine mandates.

InComm Payments Partners With Convey Health For OTC Services

InComm Payments is teaming up with Convey Health Solutions to offer wider access to over-the-counter (OTC) services to its health plan associates. The collaboration between the two firms will make use of Miramar, Convey’s Medicare enrollment software that serves as an end-to-end OTC benefits tool.

InComm Executive Vice President Brian Parlotto said the company will work with Convey to increase their market penetration “through the acceptance of OTC Network benefits.”

Only 12 Pct Of Firms Using AI To Fight Healthcare Fraud, Waste, Abuse

PYMNTS’ July 2021 study, “AI In Focus: Targeting Fraud, Waste And Abuse In Healthcare,” a collaboration with Brighterion, a Mastercard company, found only 12 percent of firms are using artificial intelligence to detect and address fraud, waste and abuse (FWA) in healthcare.

The study found that 83 percent of the firms that have or plan to invest in AI for FWA “consider reducing false positives as the most important expected benefit.” That portion is 100 percent for firms that generate more than $1 billion in annual revenue. More than three-quarters of respondents in other revenue brackets cite it as the most important expected benefit. The study explores how companies are combatting FWA with AI smarts.